Fund Name | : | ICICI Prudential Mutual Fund |
Scheme Name | : | ICICI Pru P.H.D Fund (IDCW) |
AMC | : | ICICI Prudential Mutual Fund |
Type | : | O |
Category | : | Equity - Pharma |
Launch Date | : | 25-Jun-2018 |
Fund Manager | : | Dharmesh Kakkad |
Net Assets (Rs. cr) | : | 3772.32 |
Invest wise with Expert advice
Get better recommendations Make better investments.
Get better recommendations Make better investments.
By continuing, I accept the Terms & Conditions and agree to receive communication on Whatsapp
NAV Date | : | 18-Apr-2024 |
NAV [Rs.] | : | 20.88 |
Buy/Resale Price [Rs.] | : | 0 |
Sell/Repurchase Price [Rs.] | : | 0 |
Entry Load % | : | Nil |
Exit Load % | : | 1.00% - If units purchased or switched in from another scheme of the fund are redeemed or switched out within 18 months from the date of allotment Nil - If units purchased or switched in from another scheme of the fund are redeemed or switched out after 18 months from the date of allotment |
1w | 1m | 3m | 6m | 1y | 3y | 5y | Since INC | |
---|---|---|---|---|---|---|---|---|
Scheme Returns | -2.20 | 1.61 | 7.63 | 24.06 | 56.33 | 17.69 | 24.07 | 21.11 |
Category Avg | -2.36 | 1.65 | 6.09 | 22.28 | 50.27 | 16.33 | 23.12 | 18.98 |
Category Best | -0.95 | 6.06 | 9.11 | 26.99 | 57.77 | 19.68 | 27.27 | 37.37 |
Category Worst | -2.20 | 1.61 | 7.63 | 24.06 | 56.33 | 17.69 | 24.07 | 21.11 |
Dividends | Bonus | |
---|---|---|
Ratio | 15.50 | 0.00 |
Date | 10-08-2023 | 10-08-2023 |
Min. Investment(Rs.) | : | 5000 |
Increm.Investment(Rs.) | : | 1000 |
Calculate the worth of your wealth at retirement
In | |
Name of the Company | No of shares |
No Record Found
Out | |
Name of the Company | No of shares |
No Record Found
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) | ||||
---|---|---|---|---|---|---|---|---|---|
Equity & Equity related Investments | |||||||||
Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 15.24 | 35,46,501.00 | 574.73 | ||||
Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 7.19 | 4,40,724.00 | 271.39 | ||||
Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.68 | 7,31,295.00 | 251.95 | ||||
Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 6.56 | 22,74,054.00 | 247.59 | ||||
Equity | Apollo Hospitals | Healthcare Services | 6.45 | 3,82,552.00 | 243.18 | ||||
Equity | Lupin | Pharmaceuticals & Biotechnology | 5.93 | 13,82,453.00 | 223.51 | ||||
Equity | Cipla | Pharmaceuticals & Biotechnology | 5.31 | 13,38,334.00 | 200.34 | ||||
Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.38 | 5,54,841.00 | 127.66 | ||||
Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.49 | 1,90,216.00 | 94.00 | ||||
Equity | Fortis Health. | Healthcare Services | 2.48 | 22,24,214.00 | 93.46 | ||||
Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.08 | 7,77,858.00 | 78.36 | ||||
Equity | HDFC Life Insur. | Insurance | 2.03 | 12,08,404.00 | 76.53 | ||||
Equity | FDC | Pharmaceuticals & Biotechnology | 1.97 | 17,52,436.00 | 74.46 | ||||
Equity | Syngene Intl. | Healthcare Services | 1.78 | 9,54,039.00 | 67.03 | ||||
Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 1.61 | 1,13,932.00 | 60.71 | ||||
Equity | Health.Global | Healthcare Services | 1.54 | 17,16,495.00 | 57.99 | ||||
Equity | Shilpa Medicare | Pharmaceuticals & Biotechnology | 1.52 | 12,45,731.00 | 57.37 | ||||
Equity | Vijaya Diagnost. | Healthcare Services | 1.44 | 8,54,940.00 | 54.43 | ||||
Equity | Krsnaa Diagnost. | Healthcare Services | 1.43 | 8,80,174.00 | 54.10 | ||||
Equity | Aster DM Health. | Healthcare Services | 1.32 | 12,14,884.00 | 49.73 | ||||
Equity | Star Health Insu | Insurance | 1.28 | 8,91,118.00 | 48.43 | ||||
Equity | Atul | Chemicals & Petrochemicals | 1.23 | 80,733.00 | 46.34 | ||||
Equity | Thyrocare Tech. | Healthcare Services | 1.20 | 7,65,047.00 | 45.13 | ||||
Equity | Windlas Biotech | Pharmaceuticals & Biotechnology | 1.16 | 8,57,651.00 | 43.77 | ||||
Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.14 | 3,48,827.00 | 43.16 | ||||
Equity | Blue Jet Health | Pharmaceuticals & Biotechnology | 1.10 | 10,80,413.00 | 41.37 | ||||
Equity | SBI Life Insuran | Insurance | 1.07 | 2,68,012.00 | 40.21 | ||||
Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 1.06 | 2,06,227.00 | 40.14 | ||||
Equity | Yatharth Hospit. | Healthcare Services | 1.06 | 9,52,357.00 | 40.03 | ||||
Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.02 | 2,09,375.00 | 38.63 | ||||
Equity | Navin Fluo.Intl. | Chemicals & Petrochemicals | 1.01 | 1,22,006.00 | 38.00 | ||||
Equity | Laxmi Organic | Chemicals & Petrochemicals | 0.97 | 15,62,569.00 | 36.75 | ||||
Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 0.96 | 3,78,822.00 | 36.31 | ||||
Equity | Wockhardt | Pharmaceuticals & Biotechnology | 0.90 | 5,80,271.00 | 33.99 | ||||
Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 0.85 | 24,83,950.00 | 32.02 | ||||
Equity | Advanced Enzyme | Pharmaceuticals & Biotechnology | 0.79 | 8,58,274.00 | 29.91 | ||||
Equity | Galaxy Surfact. | Chemicals & Petrochemicals | 0.78 | 1,29,047.00 | 29.31 | ||||
Equity | P & G Health Ltd | Pharmaceuticals & Biotechnology | 0.71 | 56,762.00 | 26.73 | ||||
Equity | Aarti Pharma | Pharmaceuticals & Biotechnology | 0.69 | 5,99,283.00 | 26.07 | ||||
Equity | ERIS Lifescience | Pharmaceuticals & Biotechnology | 0.44 | 1,95,719.00 | 16.51 | ||||
Equity | Pfizer | Pharmaceuticals & Biotechnology | 0.30 | 27,228.00 | 11.42 | ||||
Equity | Hikal | Pharmaceuticals & Biotechnology | 0.29 | 4,18,600.00 | 11.10 | ||||
Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 0.11 | 15,943.00 | 4.15 | ||||
Equity | Innova Captab | Pharmaceuticals & Biotechnology | 0.08 | 66,270.00 | 2.98 | ||||
Equity | Thirumalai Chem. | Chemicals & Petrochemicals | 0.06 | 1,04,783.00 | 2.45 | ||||
Cash & Cash Equivalent | |||||||||
Reverse Repo | TREPS | -/- | 0.87 | 0.00 | 32.77 | ||||
Net CA & Others | Net CA & Others | -/- | 0.43 | 0.00 | 16.13 | ||||
Derivative Investments | |||||||||
Derivatives | Cash Margin - Derivatives | -/- | 0.00 | 0.00 | 0.01 |
Fund House | : ICICI Prudential Asset Management Co Ltd |
Incorporation Date | : 22-Jun-1993 |
Total Assets Managed (Cr.) | : 7,11,553.09 |
Trustee/s | : Mr. Lakshman Kumar Mylava |
Chairman | : N/A |
CEO / MD | : Mr. Nimesh Shah |
CIO | : N/A |
President | : N/A |
Director/s | : Ms.Anubhuti Sanghai |
Compliance Officer/s | : N/A |
Investor Service Officer/s | : Rajen Kotak |
Fund Manager/s | : Dharmesh Kakkad |
Auditors | : N/A |
Registered Office | : One BKC, A-Wing, 13th Floor, Bandra Kurla Complex, Mumbai 400051 |
Contact Nos | : 26525000 |
Fax | : 26528100 |
: enquiry@icicipruamc.com | |
Website | : www.icicipruamc.com |
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Copyright © IIFL Securities Ltd. All rights Reserved.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This certificate demonstrates that IIFL as an organization has defined and put in place best-practice information security processes.